Company profile: Solve Therapeutics
1.1 - Company Overview
Company description
- Provider of biopharmaceutical therapies developing antibody-drug conjugates and bispecific therapeutics.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Solve Therapeutics
Gilead
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies for critical diseases, discovering, developing, manufacturing and commercializing treatments across virology, oncology and inflammation. Portfolio includes Biktarvy and Descovy for HIV-1 (treatment and PrEP) and Epclusa for HCV, with efforts to transform viral diseases into manageable conditions and expand access to care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gilead company profile →
Animol Discovery
HQ: United States
Website
- Description: Provider of a drug discovery platform combining DNA-encoded chemical libraries, AI/ML, and computational chemistry to rapidly identify novel veterinary medicines; focuses on discovering and developing small-molecule drugs for companion and farm animals addressing infectious and chronic diseases, with a proprietary pipeline of veterinary small molecules including next-generation antiparasitics and therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Animol Discovery company profile →
Avivia
HQ: The Netherlands
Website
- Description: Provider of pharmaceutical CRO services, including analytical testing, drug formulation, generic drugs, repurposing, and troubleshooting.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avivia company profile →
Navitor Pharmaceuticals
HQ: United States
Website
- Description: Provider of novel medicines targeting nutrient-sensing proteins, including NV-5138, an orally bioavailable small molecule that directly activates mTORC1 for treatment-resistant depression, and AT-20494, a selective mTORC1 inhibitor for autosomal dominant polycystic kidney disease and potentially other conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Navitor Pharmaceuticals company profile →
VivaBioCell
HQ: Italy
Website
- Description: Provider of innovative products leveraging proprietary cell culture and tissue engineering technologies for early diagnosis of autoimmune diseases (e.g., scleroderma, graft-versus-host disease) and treatment of oro-dental and maxillo-facial defects.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full VivaBioCell company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Solve Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Solve Therapeutics
2.2 - Growth funds investing in similar companies to Solve Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Solve Therapeutics
4.2 - Public trading comparable groups for Solve Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →